271 related articles for article (PubMed ID: 26446354)
1. High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors.
Koizume S; Ito S; Yoshioka Y; Kanayama T; Nakamura Y; Yoshihara M; Yamada R; Ochiya T; Ruf W; Miyagi E; Hirahara F; Miyagi Y
Thromb Haemost; 2016 Jan; 115(2):299-310. PubMed ID: 26446354
[TBL] [Abstract][Full Text] [Related]
2. Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.
Gomes FG; Sandim V; Almeida VH; Rondon AMR; Succar BB; Hottz ED; Leal AC; Verçoza BRF; Rodrigues JCF; Bozza PT; Zingali RB; Monteiro RQ
Thromb Res; 2017 Nov; 159():24-32. PubMed ID: 28950217
[TBL] [Abstract][Full Text] [Related]
3. Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.
Yokota N; Koizume S; Miyagi E; Hirahara F; Nakamura Y; Kikuchi K; Ruf W; Sakuma Y; Tsuchiya E; Miyagi Y
Br J Cancer; 2009 Dec; 101(12):2023-9. PubMed ID: 19904262
[TBL] [Abstract][Full Text] [Related]
4. Biologically Active Tissue Factor-Bearing Larger Ectosome-Like Extracellular Vesicles in Malignant Effusions from Ovarian Cancer Patients: Correlation with Incidence of Thrombosis.
Steidel C; Ender F; Rody A; von Bubnoff N; Gieseler F
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466775
[TBL] [Abstract][Full Text] [Related]
5. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol Starvation and Hypoxia Activate the FVII Gene via the SREBP1-GILZ Pathway in Ovarian Cancer Cells to Produce Procoagulant Microvesicles.
Koizume S; Takahashi T; Yoshihara M; Nakamura Y; Ruf W; Takenaka K; Miyagi E; Miyagi Y
Thromb Haemost; 2019 Jul; 119(7):1058-1071. PubMed ID: 31055798
[TBL] [Abstract][Full Text] [Related]
7. Filamin-A is required for the incorporation of tissue factor into cell-derived microvesicles.
Collier ME; Maraveyas A; Ettelaie C
Thromb Haemost; 2014 Apr; 111(4):647-55. PubMed ID: 24258684
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the Filamin A-Dependent Mechanisms of Tissue Factor Incorporation into Microvesicles.
Collier MEW; Ettelaie C; Goult BT; Maraveyas A; Goodall AH
Thromb Haemost; 2017 Nov; 117(11):2034-2044. PubMed ID: 29044292
[TBL] [Abstract][Full Text] [Related]
9. Role of the tissue factor pathway in the biology of tumor initiating cells.
Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor mediates microvesicles shedding from MDA-MB-231 breast cancer cells.
Rondon AMR; de Almeida VH; Gomes T; Verçoza BRF; Carvalho RS; König S; Rodrigues JCF; Mermelstein CDS; Versteeg HH; Monteiro RQ
Biochem Biophys Res Commun; 2018 Jul; 502(1):137-144. PubMed ID: 29787758
[TBL] [Abstract][Full Text] [Related]
11. Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply.
Koizume S; Miyagi Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417928
[TBL] [Abstract][Full Text] [Related]
12. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis.
Strukova S
Front Biosci; 2006 Jan; 11():59-80. PubMed ID: 16146714
[TBL] [Abstract][Full Text] [Related]
13. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk.
Abu Saadeh F; Norris L; O'Toole S; Mohamed BM; Langhe R; O'Leary J; Gleeson N
Thromb Res; 2013 Nov; 132(5):627-34. PubMed ID: 24094893
[TBL] [Abstract][Full Text] [Related]
14. Detection of tissue factor-positive extracellular vesicles by laser scanning confocal microscopy.
Hisada Y; Auriemma AC; Alexander W; Ay C; Mackman N
Thromb Res; 2017 Feb; 150():65-72. PubMed ID: 28043041
[TBL] [Abstract][Full Text] [Related]
15. Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis.
Almeida VH; Rondon AMR; Gomes T; Monteiro RQ
Cells; 2019 Jul; 8(7):. PubMed ID: 31337034
[TBL] [Abstract][Full Text] [Related]
16. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
Jiang X; Zhu S; Panetti TS; Bromberg ME
Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
[TBL] [Abstract][Full Text] [Related]
17. PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells.
Fang Y; Garnier D; Lee TH; D'Asti E; Montermini L; Meehan B; Rak J
Angiogenesis; 2016 Jan; 19(1):25-38. PubMed ID: 26374632
[TBL] [Abstract][Full Text] [Related]
18. Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer.
Hu Z; Xu J; Cheng J; McMichael E; Yu L; Carson WE
Oncotarget; 2017 Jan; 8(1):1481-1494. PubMed ID: 27903969
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles from amniotic fluid, milk, saliva, and urine expose complexes of tissue factor and activated factor VII.
Hu Y; Repa A; Lisman T; Yerlikaya-Schatten G; Hau C; Pabinger I; Ay C; Nieuwland R; Thaler J
J Thromb Haemost; 2022 Oct; 20(10):2306-2312. PubMed ID: 35748324
[TBL] [Abstract][Full Text] [Related]
20. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
